-
SFRP1 Suppresses Wnt/β-Catenin to Alleviate Oral Submucous F
2026-08-04
The referenced study demonstrates that SFRP1 overexpression reduces neutrophil infiltration and inhibits the Wnt/β-catenin pathway, leading to attenuation of oral submucous fibrosis (OSF) in an arecoline-induced mouse model. These findings clarify a mechanistic link between immune cell infiltration, fibrogenesis, and canonical Wnt signaling, providing direction for future anti-fibrotic strategies.
-
Fludarabine (A5424): Reliable DNA Synthesis Inhibition in On
2026-08-04
This article explores how Fludarabine (SKU A5424) addresses key laboratory challenges in cell viability, proliferation, and apoptosis assays for leukemia and multiple myeloma research. Drawing on validated protocols, peer-reviewed data, and direct workflow scenarios, we demonstrate why Fludarabine delivers reproducible, data-backed results and workflow flexibility for experimental oncology.
-
MnTBAP Chloride: Applied Workflows for Oxidative Stress Rese
2026-08-03
MnTBAP Chloride stands out as a cell-permeable SOD mimetic that reliably attenuates mitochondrial oxidative stress in both in vitro and in vivo models. This article unpacks protocol enhancements, troubleshooting strategies, and data-backed use-cases, especially for neuroinflammation and depression-like behavior models, leveraging APExBIO’s research-grade formulation.
-
Sulfo-NHS-Biotin: Precision Protein Labeling for Advanced As
2026-08-03
Sulfo-NHS-Biotin stands out as a water-soluble, amine-reactive biotinylation reagent, enabling selective and robust cell surface protein labeling. Its unique chemistry streamlines workflows in affinity capture, proteomics, and immunoprecipitation, outperforming traditional NHS-biotin for high-specificity applications.
-
Sulforaphane Suppresses NLRP3 Inflammasome in Ulcerative Col
2026-08-02
This study demonstrates that sulforaphane, a natural isothiocyanate, reduces oxidative stress and inhibits NLRP3 inflammasome activation in a dextran sodium sulfate-induced mouse model of ulcerative colitis. These findings provide mechanistic insight into sulforaphane’s anti-inflammatory action and highlight its potential as a research tool for dissecting the interplay between redox biology and innate immune signaling in inflammatory bowel disease.
-
Hematoxylin and Eosin Staining Kit: Protocol and Lab Guidanc
2026-08-01
The Hematoxylin and Eosin Staining Kit (SKU K1142) addresses the need for consistent, high-contrast visualization of cellular and tissue morphology in paraffin-embedded, frozen, or cytological research samples. It is not intended for diagnostic or medical use, and is best applied where morphological assessment, not molecular specificity, is required.
-
Phosbind Biotin LC: Practical Guide for Western Blot Phospho
2026-07-31
Phosbind Biotin LC provides a sequence-independent approach for detecting phosphorylated proteins on PVDF membranes in Western Blot workflows. It is best suited where phospho-specific antibodies are unavailable or sequence context is limiting, but is not recommended for aqueous-only protocols or situations requiring long-term storage of working solutions.
-
Gemcitabine HCl (SKU A1402): Reliable Cytotoxicity for Pancr
2026-07-31
This article provides a scenario-driven, evidence-based exploration of best practices for using Gemcitabine HCl (SKU A1402) in cell viability, cytotoxicity, and in vivo tumor suppression assays. By addressing real laboratory challenges—from solubility and protocol integration to data interpretation and supplier selection—researchers gain practical insights to optimize experimental reproducibility using APExBIO’s validated reagent.
-
HMGCS2 Downregulation Drives LysoPC-Mediated Pulmonary Fibro
2026-07-30
Yang et al. (2024) reveal that suppression of HMGCS2 in type II alveolar epithelial cells disrupts lipid metabolism, leading to the accumulation of 14:0 Lyso-PC, which in turn activates lung fibroblasts and promotes pulmonary fibrosis. These findings link epithelial lipid metabolic changes to fibrogenesis and highlight new mechanistic targets for intervention in idiopathic pulmonary fibrosis.
-
hCG Regulates CXCL10 via EZH2-Dependent H3K27 Methylation in
2026-07-30
This study uncovers how human chorionic gonadotropin (hCG) modulates immune cell recruitment at the maternal-fetal interface by suppressing CXCL10 expression through EZH2-mediated H3K27me3 histone methylation in human decidual stromal cells. The findings clarify a key epigenetic mechanism that maintains immune tolerance during early pregnancy and suggest new research avenues for studying EZH2 function in tissue-specific immunoregulation.
-
Propranolol: Applied Workflows for Cardiovascular and Memory
2026-07-29
Propranolol, a non-selective β-adrenergic receptor blocker, empowers researchers to dissect metabolic, cardiovascular, and neurobehavioral pathways with precision. This article distills advanced protocol guidance, comparative use-case insights, and troubleshooting strategies leveraging APExBIO’s high-purity Propranolol for reliable, translational research impact.
-
MDL 28170 Calpain Inhibitor: Advanced Workflows for Neuropro
2026-07-29
MDL 28170 stands out as a potent, selective calpain and cathepsin B inhibitor with proven efficacy in neuroprotection and apoptosis assays. Its rapid blood-brain barrier penetration and nanomolar potency make it a gold standard for translational research in ischemia-reperfusion injury and neurodevelopmental models.
-
Valemetostat (DS-3201): Applied Workflows in Lymphoma Resear
2026-07-28
Valemetostat (DS-3201) empowers translational researchers with precise and selective dual EZH1/EZH2 inhibition, driving advances in relapsed/refractory lymphoma models. This guide delivers actionable workflow enhancements, troubleshooting strategies, and data-driven insights for maximizing the compound's impact in preclinical epigenetic cancer therapy.
-
Y-27632: Decoding ROCK Inhibition in Cancer Immunity Researc
2026-07-28
Explore the multifaceted role of Y-27632, a benchmark ROCK inhibitor, in advanced cancer biology and immune evasion studies. This article provides a unique, translational perspective on its use in dissecting cytoskeletal dynamics and tumor immune resistance.
-
Lycopene Mitigates DON-Induced Intestinal Damage via ERK Pat
2026-07-27
This study demonstrates that lycopene can reverse deoxynivalenol (DON)-induced intestinal barrier dysfunction and NLRP3 inflammasome activation by targeting the ERK pathway in IPEC-J2 cells. The findings advance understanding of dietary antioxidants as potential interventions against mycotoxin-induced gut injury and highlight mechanistic insights for future translational research.
451 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page